Aarkstore Market Research entitles the new approach into a Market Research Report “Hematology Diagnostic Devices And Equipment Global Market Report 2020”
Hematology Diagnostic Devices And Equipment Market Global Report 2020 provides strategists, marketers and senior management with the critical information they need to assess the global hematology diagnostic devices and equipment market.
Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the hematology diagnostic devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Hematology Diagnostic Devices And Equipment Market Global Report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.
• The Market Characteristics section of the report defines and explains the market.
• The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
• Market Segmentations break down market into sub markets.
• The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
• Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
Scope
Markets Covered:
1) By Product: Instruments, Consumables
2) By End User: Hospitals, Specialized Diagnostic Centers, Specialized Research Institutes
3) By Instruments: Analyzers, Flow cytometers, Others
4) By Consumables: Reagents, Stains, Others
5) By Application: Drug Testing, Auto-Immune Disease, Cancer, Diabetes Mellitus, Infectious Disease, Other Applications
Companies Mentioned: Abbott Diagnostics, Beckman Coulter, Bio-Rad Laboratories, Drucker Diagnostics, Horiba Ltd
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time Series: Five years historic and forecast.
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.
The hematology diagnostics devices and equipment market consist of sales of hematology diagnostics devices and related services. Hematology diagnostics instruments are used to diagnose diseases related to blood, vascular systems, bone marrow, autoimmune disorders, and hemostasis. These devices include automated cell counters, red cell indices devices, micro sedimentation centrifuges, or blood volume measuring devices, occult blood tests, platelet aggregometer, erythrocyte sedimentation rate tests, red blood cell enzyme assay kits, glutathione reductase assays, and hematology reagents.
The global hematology diagnostic devices and equipment market was valued at about $1.9 billion in 2018 and is expected to grow to $2.35 billion at a CAGR of 5.5% through 2022.
Hematology diagnostic devices are driven by the increase in the prevalence of blood disorders. Hematology diagnostic devices are widely used in order to identify the type of blood disorder. A blood disorder is a condition that is impacting the count of the blood cells like red blood cells, white blood cells, platelets, etc. Blood disorder affecting millions of people each year across the world irrespective of age, race, and sex. E.g.. As per the World Health Organization, Hemoglobin disorder is affecting 75% of the total births globally and the prevalence of Anemia is 12.7% is men.
A product recall is one of the major problems that the companies are facing. Product recalls is the process of returning the faulty devices which can be due to the errors in the manufacturing of the device. Because of the faulty devices tests conducted in the diagnostic centers may get affected. For example, In 2018, Becton Dickinson (BD) and Company recalled Vacutainer EDTA Blood Collection Tubes because they are affecting the test due to the chemical interference of test tubes with the blood samples. This recall was classified as Class I recall, the most serious type of recall, by the Food and Drug Administration (FDA). Such product recalls can negatively affect market growth.
Companies in the hematology diagnostic devices are increasingly investing in automation technology. Automation technology advancements are driving the demand for hematology analyzers and this automation will reduce the errors caused due to manual practices in the diagnostic centers. Example top companies like Sysmex acquired CLIA waiver for a newly automated hematology analyzer and by selling this product, Sysmex makes it possible for clinical facilities to perform hematology testing without any manual errors.
CLIA regulations establish quality standards for laboratory testing performed on specimens from humans, such as blood, body fluid, and tissue, for the purpose of diagnosis, prevention, or treatment of disease, or assessment of health.
The hematology diagnostic devices market has a potential market to grow rapidly but stringent regulatory policies are restricting their growth. The FDA currently regulates class I, class II, and class III hematology devices. This means that class I hemostasis devices are regulated to use these devices are exempt from the premarket notification requirements and they only be used for the general controls. Regulations for class II devices are exempt from the premarket notification requirements and they can be used for special controls. Class III is the most stringent category as it requires
premarket approval (PMA).
Major players in the market are Abbott Diagnostics, Beckman Coulter, Bio-Rad Laboratories, Drucker Diagnostics, Horiba Ltd
To See More Reports of This Category: https://www.aarkstore.com/healthcare
Aarkstore Enterprise provides businesses, start- ups, market research seekers and enthusiasts with all-inclusive yet exclusive market information encompassing a number of industry verticals. As a leading online market research reseller, Aarkstore acts as a platform for accessing statistics, forecasts, business insights, ideas, concepts and much more.
Contact Details:
Aarkstore Enterprise
Phone: +91 – 22 2756 4963
24/7 Online Support: +91 9987295242
Email: enquiry@aarkstore.com
Our website: https://www.aarkstore.com
Our blog: https://www.aarkstore.com/blog
Follow us on LinkedIn – https://www.linkedin.com/company/aarkstore-enterprise/
industryanalysisreports 